Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Lifecore Biomedical, Inc. - Common Stock (NQ:LFCR)

6.828 -0.372 (-5.17%)
Streaming Delayed Price Updated: 2:49 PM EDT, Apr 3, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 173,053
Open 6.820
Bid (Size) 6.800 (2)
Ask (Size) 6.830 (1)
Prev. Close 7.200
Today's Range 6.740 - 7.045
52wk Range 3.679 - 7.990
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Earnings Scheduled For April 3, 2025
Via Benzinga
Lifecore Biomedical Announces Special Stockholder Meeting
Company Seeking to Remove Convertible Preferred Stock Exchange Cap to Permit Potential Conversion of Series A Preferred Stock as Contemplated by the Series A Preferred Stock Terms 
From Lifecore Biomedical, Inc.
Via GlobeNewswire

Performance

YTD
+2.5%
+2.5%
1 Month
+19.4%
+19.4%
3 Month
+2.5%
+2.5%
6 Month
+37.4%
+37.4%
1 Year
+23.7%
+23.7%

More News

Read More
Lifecore Biomedical Further Strengthens Financial Position Through Sale of Excess Capital Equipment for $17 Million
From Lifecore Biomedical, Inc.
Via GlobeNewswire
Lifecore Biomedical Earnings Report: Q2 Overview
Via Benzinga
Earnings Scheduled For January 2, 2025
Via Benzinga
Lifecore Biomedical to Participate at 43rd Annual J.P. Morgan Healthcare Conference
From Lifecore Biomedical, Inc.
Via GlobeNewswire
US Stocks Poised To Open Higher As Futures Advance: Tesla, Bumble, Lifecore Bio In Focus
Via Benzinga
Resources Connection, SPS Commerce And 3 Stocks To Watch Heading Into Friday
Via Benzinga
Lifecore Biomedical Reports Second Quarter Fiscal 2025 Financial Results and Provides Corporate Update
From Lifecore Biomedical, Inc.
Via GlobeNewswire
Nio, Li Auto And 3 Stocks To Watch Heading Into Thursday
Via Benzinga
S&P 500 Surges 23% In 2024, But Greed Index Remains In 'Fear' Zone
Via Benzinga
Topics Stocks
Exposures US Equities
Lifecore Biomedical to Report Financial Results for Second Quarter of Fiscal 2025 on January 2, 2025
From Lifecore Biomedical, Inc.
Via GlobeNewswire
Lifecore Biomedical Selected by Nirsum Labs to Provide CDMO Services Supporting Clinical Development of Innovative Opioid Use Disorder Treatment
From Lifecore Biomedical, Inc.
Via GlobeNewswire
Lifecore Biomedical Amends and Extends Revolving Credit Facility with BMO
From Lifecore Biomedical, Inc.
Via GlobeNewswire
Lifecore Biomedical Hosts Virtual Investor Day
From Lifecore Biomedical, Inc.
Via GlobeNewswire
Lifecore Biomedical to Present at Stephens Annual Investment Conference
From Lifecore Biomedical, Inc.
Via GlobeNewswire
Lifecore Biomedical to Host Virtual Investor Day Prior to Market Open on November 21, 2024
From Lifecore Biomedical, Inc.
Via GlobeNewswire
Lifecore Biomedical Appoints Thomas Guldager as Vice President, Operations
From Lifecore Biomedical, Inc.
Via GlobeNewswire
Lifecore Biomedical Reports First Quarter of Fiscal 2025 Financial Results and Provides Corporate Update
From Lifecore Biomedical, Inc.
Via GlobeNewswire
Lifecore Biomedical Raises $24.3 Million in Private Placement of Common Stock
From Lifecore Biomedical, Inc.
Via GlobeNewswire
Apogee Enterprises, Smart Sand And 3 Stocks To Watch Heading Into Friday
Via Benzinga
Lifecore Biomedical to Report Financial Results for First Quarter of Fiscal 2025 Prior to Market Open on October 4, 2024
From Lifecore Biomedical, Inc.
Via GlobeNewswire
Lifecore Biomedical Selected by Lindy Biosciences to Support Process Development and Commercial Scale-Up for Innovative Microglassification Formulation Technology
From Lifecore Biomedical, Inc.
Via GlobeNewswire
LFCR Investors Have Opportunity to Lead Lifecore Biomedical, Inc. Securities Fraud Lawsuit with the Schall Law Firm
From The Schall Law Firm
Via Business Wire
The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Lifecore Biomedical, Inc. (LFCR)
From The Law Offices of Frank R. Cruz
Via Business Wire

Frequently Asked Questions

Is Lifecore Biomedical, Inc. - Common Stock publicly traded?
Yes, Lifecore Biomedical, Inc. - Common Stock is publicly traded.
What exchange does Lifecore Biomedical, Inc. - Common Stock trade on?
Lifecore Biomedical, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Lifecore Biomedical, Inc. - Common Stock?
The ticker symbol for Lifecore Biomedical, Inc. - Common Stock is LFCR on the Nasdaq Stock Market
What is the current price of Lifecore Biomedical, Inc. - Common Stock?
The current price of Lifecore Biomedical, Inc. - Common Stock is 6.828
When was Lifecore Biomedical, Inc. - Common Stock last traded?
The last trade of Lifecore Biomedical, Inc. - Common Stock was at 04/03/25 02:49 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.